Nursing care of patients with Epstein-Barr virus related post-transplantation lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
10.3760/cma.j.issn.1672-7088.2017.16.007
- VernacularTitle:异基因造血干细胞移植术后合并EB病毒相关的淋巴细胞增殖性疾病患者的护理
- Author:
Bei WANG
;
Shuai ZHANG
;
Huijuan ZHANG
;
Wenjun XIE
- Keywords:
Nursing care;
Allogeneic hematopoietic stem cell transplantation;
Epstein-Barr virus;
Post-transplantation lymphoproliferative disorder;
Rituximab
- From:
Chinese Journal of Practical Nursing
2017;33(16):1227-1230
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize the nursing care measures about patients with Epstein-Barr virus related post-transplantation lymphoproliferative disorder (EBV-PTLD) after allogeneic hematopoietic stem cell transplantation. Methods The nursing care measures about five patients with EBV-PTLD after allogeneic hematopoietic stem cell transplantation from October 2014 to May 2015 were summarized and analyzed. Results After carefully treating and nursing care, three patients were discharged. One patient with exacerbations, respiratory, epilepsy, liver failure, and disseminated intravascular coagulation was automatically discharged and then died. And the other patient died of other diseases. Conclusions Epstein-Barr virus infection is a complication after allogeneic hematopoietic stem cell transplantation. The key points to prevention and treatment of EBV infection included monitoring regularly, diagnosing and early intervention, which was proved to be effective, timely and active.
